The Central Association of German Opticians (ZVA) is calling for more consistent market surveillance to ensure corrective spectacles imported directly from non-EU countries comply with European Medical Device Regulation (MDR). While local opticians face strict documentation and testing duties, the ZVA argues that international online platforms often bypass equivalent checks. Citing EU Commission data showing only 387,588 customs interventions against approximately 5.9 billion low-value e-commerce goods entering the EU in 2025, the association warns of significant control deficits. Although new EU customs rules took effect in July 2026 and mandatory product identifiers are scheduled for November, the ZVA insists these measures do not replace actual safety verification. The organization has submitted a position paper to political debates on MDR revision, advocating for targeted test purchases and better traceability to protect consumers and ensure fair competition.
Starting November 1, the European Union will levy a permanent two-euro handling fee on each type of item in packages sent directly to consumers from outside the bloc. This measure aims to curb the influx of low-value imports, particularly from China via platforms like AliExpress and Temu, and compensate customs authorities for increased workload. The fee applies regardless of parcel value and is separate from the temporary three-euro duty on small parcels introduced in July. While the EU states consumers will not pay this fee directly, online marketplaces and sellers are responsible for it and may pass costs to buyers through price adjustments. Officials note that imports have fallen by approximately 64 percent since the July duty was implemented, though they caution it is too early to draw firm conclusions.
Editorial relevance: The new EU handling fee directly impacts cross-border online retail logistics and costs for major e-commerce platforms selling into the European market.
The General Optical Council (GOC) published findings from its first thematic review into commercial practices and patient safety. The report identifies widespread concerns among registrants regarding stress, burnout, and high patient volumes, noting that students and early-career professionals are particularly affected. While patient satisfaction remains high, the review highlights barriers to accessing eyecare, including a lack of online price transparency and insufficient information on NHS financial support eligibility. It also notes concerns about pressure selling deterring routine sight tests and some businesses not providing tests for young children. The GOC states there is no direct evidence of harm but emphasizes that limited outcome data makes quality assessment difficult. Planned actions include reviewing Standards for Optical Businesses and working with education providers to address these issues.
A federal judge in California has certified a class action lawsuit against Hubble Contacts, allowing more than 95,500 California customers to pursue claims that the online contact lens subscription service sold lenses different from those prescribed by their eye doctors. The case, Africa v. Vision Path Inc., alleges Hubble exploited its prescription verification process to substitute its own one-size-fits-all lenses for doctor-prescribed brands. Plaintiffs claim misleading website statements and failed disclosures during checkout exposed consumers to potential eye injuries. The complaint also names co-founders Benjamin Cogan and Jesse Horwitz in a separate fraud conspiracy claim. This certification does not determine liability but enables collective pursuit of claims. Hubble previously paid $3.5 million in 2022 to resolve similar federal allegations.